AI Proteins

Boston, United States

AI Proteins is a biotechnology company that focuses on the de novo design and engineering of miniprotein therapeutics.

$41.5M raised

Nov 2025

Series A

Top Investors

Sante VenturesMission BioCapitalLightchain CapitalIntel IgniteCobro Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AI Proteins raised?

AI Proteins has raised $41.5M in total funding. The most recent round was Series A. The last funding was announced in November 2025.

Who are AI Proteins's investors?

AI Proteins's investors include Sante Ventures, Mission BioCapital, Lightchain Capital, Intel Ignite, Cobro Ventures.

Where is AI Proteins headquartered?

AI Proteins is headquartered in Boston, United States.

What does AI Proteins do?

AI Proteins is a biotechnology company that focuses on the de novo design and engineering of miniprotein therapeutics.

What stage is AI Proteins at?

AI Proteins is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 19, 2025.

MLA

"AI Proteins — Funding & Investors." VCBacked, November 19, 2025, https://www.vcbacked.co/company/ai-proteins. Accessed June 9, 2026.

APA

VCBacked. (2025). AI Proteins — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/ai-proteins

Wikipedia (cite web)

{{cite web |title=AI Proteins — Funding & Investors |url=https://www.vcbacked.co/company/ai-proteins |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 19, 2025.